Published in Ann Intern Med on February 20, 2007
Weight Based Enoxaparin in Trauma Patients (WeBET) | NCT01916707
Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ (2012) 1.78
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation (2009) 1.66
Cancer, clots and consensus: new understanding of an old problem. J Clin Oncol (2009) 1.35
Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis (2010) 1.26
Addressing the sociotechnical drivers of quality improvement: a case study of post-operative DVT prophylaxis computerised decision support. BMJ Qual Saf (2011) 1.04
Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors. Inflamm Bowel Dis (2014) 1.03
Venous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit. Thromb J (2011) 1.01
Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome. Clin J Am Soc Nephrol (2013) 0.98
Thromboprophylaxis for adults in hospital: Prophylaxis for medical inpatients is not entirely proven. BMJ (2007) 0.93
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis (2011) 0.86
Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. World J Gastroenterol (2014) 0.86
Prevention of venous thromboembolism in hospitalized patients with cancer. J Clin Oncol (2009) 0.85
Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery. J Thromb Haemost (2011) 0.85
Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival. Patient Relat Outcome Meas (2011) 0.85
Thrombotic risk assessment questionary helps increase the use of thromboprophylaxis for patients with pelvic and acetabular fractures. Indian J Orthop (2012) 0.84
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci (2013) 0.84
Venous thromboembolism prophylaxis in the United States: still room for improvement. J Gen Intern Med (2010) 0.83
Prevention of venous thromboembolism in medical patients and outpatients. Nat Rev Cardiol (2009) 0.82
Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country. Vasc Health Risk Manag (2009) 0.80
Measures of risk and their relationship to the relative size of a high-risk group: application to medical thromboprophylaxis. Clin Epidemiol (2012) 0.79
Unintended consequences of a standard admission order set on venous thromboembolism prophylaxis and patient outcomes. J Gen Intern Med (2011) 0.79
Enhanced antithrombotic effects of unfractionated heparin in rats after repeated oral doses and its relationship to endothelial heparin concentration. Br J Pharmacol (2008) 0.79
Clinicians adopting evidence based guidelines: a case study with thromboprophylaxis. BMC Health Serv Res (2011) 0.78
Primary prevention of venous thromboembolism in elderly medical patients. Clin Interv Aging (2008) 0.78
Venous thromboembolic events in hospitalised medical patients. Thromb Haemost (2009) 0.78
Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review. World J Gastrointest Oncol (2016) 0.77
Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhage. World J Crit Care Med (2015) 0.77
A clinical decision support system for venous thromboembolism prophylaxis at a general hospital in a middle-income country. J Bras Pneumol (2013) 0.76
Diagnosis of abdominal mural aortic thrombus following discovery of common femoral artery and vein thrombosis by point-of-care ultrasound. J Ultrasound (2015) 0.75
Asymptomatic deep vein thrombosis in a patient with major depressive disorder. Case Rep Psychiatry (2012) 0.75
Risk factors for inpatient venous thromboembolism despite thromboprophylaxis. Thromb Res (2013) 0.75
Combined aspirin and anticoagulant therapy in patients with atrial fibrillation. J Thromb Thrombolysis (2016) 0.75
Characterization of Venous Thromboembolism Risk in Medical Inpatients Using Different Clinical Risk Assessment Models. Can J Hosp Pharm (2016) 0.75
Anticoagulant prophylaxis for hospitalized medical patients. Ann Intern Med (2007) 0.75
Acupuncture safety in patients receiving anticoagulants: a systematic review. Perm J (2014) 0.75
Venous thromboprophylaxis in gastrointestinal bleeding. Can J Gastroenterol Hepatol (2015) 0.75
Multifaceted Intervention to Prevent Venous Thromboembolism in Patients Hospitalized for Acute Medical Illness: A Multicenter Cluster-Randomized Trial. PLoS One (2016) 0.75
Patient Preferences for Receiving Education on Venous Thromboembolism Prevention - A Survey of Stakeholder Organizations. PLoS One (2016) 0.75
Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux. Drug Des Devel Ther (2013) 0.75
Improving venous thromboembolism risk assessment compliance using the electronic tool in admitted medical patients. BMJ Qual Improv Rep (2015) 0.75
Blood disorders and public health. Am J Prev Med (2014) 0.75
Effect of medical thromboprophylaxis on mortality from pulmonary embolus and major bleedingy. Australas Med J (2015) 0.75
Health and life insurance as an alternative to malpractice tort law. BMC Health Serv Res (2010) 0.75
Thromboprophylaxis after hospital discharge in acutely ill medical patients: need for trials in patients who are at high risk of venous thrombosis. J Thorac Dis (2017) 0.75
The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients. Saudi Med J (2016) 0.75
Improving VTE risk assessment at point of admission to a tertiary centre cardiology ward. BMJ Qual Improv Rep (2015) 0.75
Perioperative risk factors for death among patients with symptomatic pulmonary thromboembolism. J Anesth (2017) 0.75
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.55
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood (2011) 6.50
Systematic overview of warfarin and its drug and food interactions. Arch Intern Med (2005) 5.86
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. N Engl J Med (2015) 4.50
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res (2006) 3.81
Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation (2012) 3.74
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med (2003) 3.18
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med (2012) 3.16
Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med (2007) 2.97
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann Intern Med (2002) 2.85
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med (2015) 2.63
Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med (2008) 2.51
Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med (2007) 2.50
Management of antiphospholipid antibody syndrome: a systematic review. JAMA (2006) 2.47
Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med (2006) 2.40
Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial. Anesthesiology (2012) 2.29
Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest (2013) 2.24
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban. Cleve Clin J Med (2013) 2.21
Managing new oral anticoagulants in the perioperative and intensive care unit setting. Anesthesiology (2013) 2.20
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med (2015) 2.16
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med (2013) 2.09
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians. Intern Emerg Med (2006) 2.05
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism. Intern Emerg Med (2009) 2.05
How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood (2012) 1.91
Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology (2011) 1.87
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood (2009) 1.84
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med (2006) 1.78
Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med (2013) 1.77
Brand name versus generic warfarin: a systematic review of the literature. Pharmacotherapy (2011) 1.74
Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis. JAMA (2010) 1.64
Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res (2008) 1.64
A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonography. Ann Intern Med (2005) 1.57
Elevated troponin and myocardial infarction in the intensive care unit: a prospective study. Crit Care (2005) 1.57
Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc (2009) 1.52
Reliability of electrocardiogram interpretation in critically ill patients. Crit Care Med (2006) 1.51
Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView). Am J Respir Crit Care Med (2011) 1.51
Natural history of cerebral vein thrombosis: a systematic review. Blood (2006) 1.51
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood (2012) 1.49
Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio. Crit Care Med (2011) 1.48
The new oral anticoagulants. Blood (2009) 1.48
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47
The role of recombinant factor VIIa in on-pump cardiac surgery: proceedings of the Canadian Consensus Conference. Can J Anaesth (2007) 1.46
Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis. Thromb Haemost (2011) 1.45
Examining the clinical use of hemochromatosis genetic testing. Can J Gastroenterol Hepatol (2015) 1.45
Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K. Ann Thorac Surg (2007) 1.45
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood (2013) 1.44
Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndrome. Chest (2004) 1.42
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures. J Orthop Trauma (2015) 1.40
Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb Haemost (2011) 1.40
Family history of hypertension influences left ventricular diastolic function during chronic antihypertensive therapy. Am J Hypertens (2007) 1.38
Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med (2008) 1.36
How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood (2012) 1.31
Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med (2006) 1.29
Acute management of bleeding in patients on novel oral anticoagulants. Eur Heart J (2012) 1.27
Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials. J Am Soc Nephrol (2004) 1.26
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol (2011) 1.25
BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail (2008) 1.23
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood (2012) 1.22
Unraveling severe sepsis: why did OPTIMIST fail and what's next? JAMA (2003) 1.21
Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents. Circulation (2010) 1.20
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. Am J Hematol (2009) 1.18
Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion (2009) 1.17
Prevalence and morphological types of anaemia and hookworm infestation in the medical emergency ward, Mulago Hospital, Uganda. S Afr Med J (2009) 1.16
Systematic review and meta-analysis methodology. Blood (2010) 1.14
Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. Transfusion (2010) 1.14
Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients. Crit Care Med (2010) 1.12
The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest (2010) 1.10
DHCR7 mutation carrier rates and prevalence of the RSH/Smith-Lemli-Opitz syndrome: where are the patients? Am J Med Genet A (2006) 1.09
Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes. Am J Crit Care (2006) 1.09
Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost (2009) 1.09
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res (2009) 1.07
Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Thromb Haemost (2005) 1.06
Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med (2002) 1.04
Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review. BMC Geriatr (2008) 1.03
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. Chest (2009) 1.03
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg (2006) 1.03
Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion (2010) 1.03
The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial. Transfusion (2012) 1.03
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood (2008) 1.03
Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion (2006) 1.02
Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review. J Crit Care (2009) 1.00